Fig. 8
From: Establishing and validating a new metabolic marker-driven prognosis signature for cutaneous melanoma
Functional analysis of the GALNT2 gene in normal melanocytes and tumor cells. (A) Target protein candidate biomarker prediction for GALNT2 PPI network diagram; different colors represent different functional networks. (B) GALNT2 expression in 39 melanoma cell lines. (C) Functional enrichment analysis of GALNT2 using GO (D) and KEGG (E) pathways. (E) Immunohistochemical staining showing the expression of the GALNT2 protein in normal and melanoma tissues. (F) Western blotting was performed to analyze the expression of the GALNT2 protein in PIG1, A375, and A2058 cells. (G) GALNT2 expression in normal skin tissues and tumor tissues. (*p < 0.05,**p < 0.01,****p < 0.0001).
